Standard titration schedule from trials 12-week escalation protocol: Weeks 1-4: 0.6mg weekly Initiation dose Body adapts to amylin effects Minimal side effects at this level Weight loss begins (modest) Weeks 5-8: 1.2mg weekly First dose increase (doubling) Gastric slowing becomes more noticeable Appetite suppression strengthens Accelerated weight loss Weeks 9-12: 1.8mg weekly Second increase Strong satiety effects More pronounced GI effects possible Approaching maximum efficacy Week 13+: 2.4mg weekly (maintenance) Target therapeutic dose Maximum weight loss velocity Maintained indefinitely Nausea typically resolved by this point (adapted) Why this schedule works: Gradual exposure reduces side effects 4-week intervals allow full adaptation Doubling steps (0.61.22.4) are tolerable Proven in hundreds of patients Balances speed with tolerability Use our peptide calculator and peptide dosing guide at SeekPeptides for precise calculations
A 2026 UK review of the February 2025 Nature Aging DO-HEALTH trial (1 g/day slowed biological ageing ~4 months), the Framingham red-blood-cell DHA data (~49% lower Alzheimers risk in the top group), the midlife hippocampal-volume study, the ~20% lower dementia risk from dietary omega-3, the APOE4 timing question and the honest atrial-fibrillation caveat with high-dose fish oil versus Dihexas unproven HGF/c-Met synaptogenesis, and why oily fish comes first, not a peptide Read the full review NewNutrition, Diet & Cognitive Neuroscience 4 July 2026 Dihexa for Ultra-Processed Food Brain Fog: UPF, Cognition & the HGF/c-Met Question Can Dihexa undo ultra-processed food brain fog
Most patients find it more pleasant than they expect
Many novel risk factors, such as sitting time, lack of physical activity, food abundance, sleep disturbances, and lack of micronutrients, and environmental factors, such as pollution, can produce severe mitochondrial stress, damage, and dysfunction
